by Brenda Baletti, Ph.D. A “substantial proportion” of infants immunized against the RSV virus with the monoclonal antibody shot nirsevimab — marketed by Sanofi and AstraZeneca as Beyfortus — developed…
Posts tagged as “Sanofi”
By daniel_g A U.S. Food & Drug Administration (FDA) panel recently recommended approval for AstraZeneca’s new monoclonal antibody, which supposedly protects infants and toddlers up to…